P095: Personalised Modelling of Quality-Adjusted Survival Benefit and Cost-Effectiveness of using Proton Beam Therapy inthe Treatment of Intermediate-Stage Hodgkin Lymphoma in England

Jones D., Shakir R., Candio P., Ramroth J., Wolstenholme J., Gray A., Cutter D., Ntentas G.

DOI

10.1097/01.hs9.0000890948.68238.c6

Type

Journal

HemaSphere

Publisher

Wiley

Publication Date

03/10/2022

Volume

6

Pages

43 - 44

Permalink Original publication